ReachMD

Episodes 1-3 of 3

• • 

    

    Lauren Ritterhouse, MD ,PhD

    Peer

  • 

    

    Pasi Antero Jänne, MD, PhD

    Peer

  • 

    

    Kanwal Raghav, MD

    Peer

  1

  

  RestartResume

  The Role of HER3 Expression in Advanced Solid Tumors

  The Role of HER3 Expression in Advanced Solid Tumors

  0.50 credits

• • 

    

    Kristi K. Orbaugh, MSN, NP, AOCN®

    Peer

  • 

    

    Val R. Adams, PharmD, FCCP, BCOP, FHOPA

    Peer

  • 

    

    Theresa W. Gillespie, PhD, MA, RN, FAAN

    Peer

  0

  

  RestartResume

  Advanced Practice Perspectives on CDK 4/6 Inhibitors: Paving the Way for HR+, HER2-Negative Early Breast Cancer

  Advanced Practice Perspectives on CDK 4/6 Inhibitors: Paving the Way for HR+, HER2-Negative Early Breast Cancer

  1.00 credits

• • 

    

    Floor J. Backes, MD

    Peer

  • 

    

    Robert L. Coleman, MD, FACOG, FACS

    Peer

  15

  

  RestartResume

  Keeping Pace in Women’s Cancers: Ovarian Cancer—From IO to PARP

  Keeping Pace in Women’s Cancers: Ovarian Cancer—From IO to PARP

  0.25 credits